Equities

Diaceutics PLC

Diaceutics PLC

Actions
  • Price (USD)1.37
  • Today's Change0.00 / 0.00%
  • Shares traded10.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of May 21 2024 13:05 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments162020
Total Receivables, Net5.79109.92
Total Inventory------
Prepaid expenses0.920.630.43
Other current assets, total--00.04
Total current assets233130
Property, plant & equipment, net1.902.092.13
Goodwill, net------
Intangibles, net8.821513
Long term investments0.31----
Note receivable - long term------
Other long term assets------
Total assets354845
LIABILITIES
Accounts payable0.380.760.51
Accrued expenses1.772.421.64
Notes payable/short-term debt000.13
Current portion long-term debt/capital leases0.150.120.15
Other current liabilities, total0.310.450.21
Total current liabilities2.603.752.63
Total long term debt1.061.211.29
Total debt1.211.331.56
Deferred income tax00.710.45
Minority interest------
Other liabilities, total0.090.08--
Total liabilities3.755.744.36
SHAREHOLDERS EQUITY
Common stock0.170.170.17
Additional paid-in capital373737
Retained earnings (accumulated deficit)(5.56)5.344.08
Treasury stock - common(0.31)(0.26)(0.17)
Unrealized gain (loss)------
Other equity, total--0.14(0.3)
Total equity314341
Total liabilities & shareholders' equity354845
Total common shares outstanding858484
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.